{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:18:05Z","timestamp":1784423885191,"version":"3.55.0"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T00:00:00Z","timestamp":1506470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contact Dermatitis"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Corticosteroids are among the most commonly used topical drugs. <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ontact allergy to these exists, but can be easily missed. Corticosteroid screening markers have been included in the baseline series with the aim of detecting most of the sensitized patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To assess the prevalence of contact allergy to topical corticosteroids in <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>pain and examine the usefulness of corticosteroid markers to detect contact allergy to corticosteroids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In total, 3699 patients referred to 20 dermatology departments across <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>pain for patch testing with the baseline series, including budesonide and tixocortol pivalate, were also tested with six supplementary corticosteroids (methylprednisolone aceponate, mometasone furoate, prednicarbate, clobetasol propionate, betamethasone 17\u2010valerate, and betamethasone 17,21\u2010dipropionate). Additionally, 2547 (68.8%) patients were tested with hydrocortisone 17\u2010butyrate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty\u2010four patients showed positive reactions to at least one of all tested corticosteroids (1.46%). Thirty\u2010nine (1.05%) reacted to at least one of the additionally tested corticosteroids; among these, 24 of 39 (61.5%) did not react to any of the corticosteroid allergy screening markers tested.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>More than half of the patients who were allergic to the additionally tested corticosteroids were not detected with the corticosteroid allergy markers. An update of the corticosteroid allergy screening markers is encouraged, with consideration of group 3 corticosteroids.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cod.12874","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T08:35:13Z","timestamp":1506501313000},"page":"76-82","source":"Crossref","is-referenced-by-count":22,"title":["Are the <scp>S<\/scp>panish baseline series markers sufficient to detect contact allergy to corticosteroids in <scp>S<\/scp>pain? <scp>A GEIDAC<\/scp> prospective study"],"prefix":"10.1111","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8309-9725","authenticated-orcid":false,"given":"Pedro","family":"Mercader\u2010Garc\u00eda","sequence":"first","affiliation":[{"name":"Dermatology Department Hospital General Universitario Jose M\u00aa Morales Meseguer  30008 Murcia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8382-5419","authenticated-orcid":false,"given":"Mar\u00eda A.","family":"Pastor\u2010Nieto","sequence":"additional","affiliation":[{"name":"Dermatology Department Hospital Universitario de Guadalajara  19002 Guadalajara Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Garc\u00eda\u2010Doval","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n of the Fundaci\u00f3n Piel Sana AEDV of the Spanish Academy of Dermatology  28008 Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gim\u00e9nez\u2010Arnau","sequence":"additional","affiliation":[{"name":"Dermatology Department Hospital del Mar  08003 Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Gonz\u00e1lez\u2010P\u00e9rez","sequence":"additional","affiliation":[{"name":"Dermatology Department Hospital Universitario de Araba  01009 Vitoria\u2010Gasteiz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Fern\u00e1ndez\u2010Redondo","sequence":"additional","affiliation":[{"name":"Dermatology Deparment Hospital Gil\u2010Casares  15706 Santiago de Compostela Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Serra\u2010Baldrich","sequence":"additional","affiliation":[{"name":"Dermatology Deparment Hospital Sant Pau  08025 Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Cordoba\u2010Guijarro","sequence":"additional","affiliation":[{"name":"Dermatology Deparment Hospital Universitario de Fuenlabrada  28942 Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8203-5834","authenticated-orcid":false,"given":"Mar\u00eda E.","family":"Gatica\u2010Ortega","sequence":"additional","affiliation":[{"name":"Dermatology Deparment Complejo Hospitalario Virgen del Valle  45071 Toledo Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Silvestre\u2010Salvador","sequence":"additional","affiliation":[{"name":"Dermatology Department Hospital General de Alicante  03010 Alicante Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"GEIDAC\u00b6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,27]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1952.72"},{"key":"e_1_2_7_3_1","first-page":"181","article-title":"Allergic contact dermatitis to corticosteroids","volume":"30","author":"Alani M D","year":"1972","journal-title":"Ann Allergy"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01634989-199209000-00003"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1992.tb00290.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb14847.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1996.tb02264.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1995.tb00535.x"},{"key":"e_1_2_7_9_1","first-page":"41","article-title":"Recommendation to include budesonide and tixocortol pivalate in the European standard series","volume":"43","author":"Isaksson M","year":"2000","journal-title":"Contact Dermatitis"},{"key":"e_1_2_7_10_1","unstructured":"TRUE TEST full prescribing information. Available at:http:\/\/www.smartpractice.com\/dermatologyallergy\/pdfs\/29543SmartPUSBrugs52\u20100292\u2010001.pdf(last accessed 6 November 2016)."},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb01396.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archderm.1995.01690130033006","article-title":"Studies in patients with corticosteroid contact allergy: understanding cross\u2010reactivity among different steroids","volume":"131","author":"Lepoittevin J P","year":"1995","journal-title":"Arch Dermatol"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02666.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01602.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2015.07.007"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12432"},{"key":"e_1_2_7_17_1","first-page":"641","article-title":"Dermatitis de contacto por corticoides t\u00f3picos","volume":"84","author":"Jones M","year":"1993","journal-title":"Actas Dermosifiliogr"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000251"},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2310\/6620.2010.10027","article-title":"Pattern of corticosteroid allergy in Thailand","volume":"21","author":"Wattanakrai P","year":"2010","journal-title":"Dermatitis"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06513.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2011.01967.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2008.01458.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04816.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1996.tb02226.x"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcod.12874","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cod.12874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T23:46:25Z","timestamp":1696031185000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cod.12874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,27]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1111\/cod.12874"],"URL":"https:\/\/doi.org\/10.1111\/cod.12874","archive":["Portico"],"relation":{},"ISSN":["0105-1873","1600-0536"],"issn-type":[{"value":"0105-1873","type":"print"},{"value":"1600-0536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,27]]}}}